Track the 파로스아이바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 파로스아이바이오 has published 17 reports. The latest transaction was reported on 4 June 2026 (Purchase). Among the most active insiders: 윤정혁. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
17 of 17 declarations
Paros I Bio is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for disease treatment.